204 results on '"Melton-Celsa, Angela"'
Search Results
2. Further Evaluation of Enterohemorrhagic Escherichia coli Gold Nanoparticle Vaccines Utilizing Citrobacter rodentium as the Model Organism
3. Trust Your Gut : Establishing Confidence in Gastrointestinal Models - An Overview of the State of the Science and Contexts of Use
4. Shiga toxin (Stx) type 2‐induced increase in O‐linked N‐acetyl glucosamine protein modification: a new therapeutic target?
5. Efficacy of EHEC gold nanoparticle vaccines evaluated with the Shiga toxin-producing Citrobacter rodentium mouse model
6. Identification and Characterization of ten Escherichia coli Strains Encoding Novel Shiga Toxin 2 Subtypes, Stx2n as Well as Stx2j, Stx2m, and Stx2o, in the United States
7. Identification and Characterization of ten Escherichia coli Strains encoding Novel Shiga Toxin 2 Subtypes, Stx2n as well as Stx2j, Stx2m, and Stx2o, in the United States
8. Differences in the Shiga Toxin (Stx) 2a Phage Regulatory Switch Region Influence Stx2 Localization and Virulence of Stx-Producing Escherichia coli in Mice
9. Shiga Toxin (Stx) Type 1a Reduces the Oral Toxicity of Stx Type 2a
10. Shiga Toxin (Stx) Type 1a and Stx2a Translocate through a Three-Layer Intestinal Model
11. Pathogenesis of Shiga-Toxin Producing Escherichia coli
12. The Presence of the pAA Plasmid in the German O104:H4 Shiga Toxin Type 2a (Stx2a)-Producing Enteroaggregative Escherichia coli Strain Promotes the Translocation of Stx2a Across an Epithelial Cell Monolayer
13. Dietary choice affects Shiga toxin-producing Escherichia coli (STEC) O157:H7 colonization and disease
14. Clinical isolates of Shiga toxin 1a--producing Shigella flexneri with an epidemiological link to recent travel to Hispaniola
15. New Therapeutic Developments against Shiga Toxin-Producing Escherichia coli
16. Shiga Toxin (Stx) Classification, Structure, and Function
17. Pathogenesis of Escherichia coli O157:H7 strain 86-24 following oral infection of BALB/c mice with an intact commensal flora
18. Neutralizing antibodies to Shiga toxin type 2 (Stx2) reduce colonization of mice by Stx2-expressing Escherichia coli O157:H7
19. Shiga Toxin-Producing Escherichia coli in Montana: Bacterial Genotypes and Clinical Profiles
20. Shiga toxin (Stx) type 2‐induced increase in O‐linked N‐acetyl glucosamine protein modification: a new therapeutic target?
21. Shiga Toxin-Producing Escherichia coli
22. Plant and Bacterial Toxins as RNAN-Glycosidases
23. A novel murine infection model for Shiga toxin-producing Escherichia coli
24. Fecal Microbiota Functional Gene Effects Related to Single-Dose Antibiotic Treatment of Travelers’ Diarrhea
25. Pathogenesis of Shiga-Toxin Producing Escherichia coli
26. Development of a hybrid Shiga holotoxoid vaccine to elicit heterologous protection against Shiga toxins types 1 and 2
27. Switching Shiga Toxin (Stx) Type from Stx2d to Stx2a but Not Stx2c Alters Virulence of Stx-Producing Escherichia coli (STEC) Strain B2F1 in Streptomycin (Str)-Treated Mice
28. Genetic and Virulence Profiles of Enteroaggregative Escherichia coli (EAEC) Isolated From Deployed Military Personnel (DMP) With Travelers' Diarrhea
29. Structure of Shiga Toxin Type 2 (Stx2) from Escherichia coli O157:H7
30. Activation of Shiga toxin type 2d (Stx2d) by elastase involves cleavage of the C-terminal two amino acids of the A2 peptide in the context of the appropriate B pentamer
31. The Virulence of Escherichia coli O157:H7 Isolates in Mice Depends on Shiga Toxin Type 2a (Stx2a)-Induction and High Levels of Stx2a in Stool
32. 1169 Travelers' Diarrhea, Single Dose Antibiotics, Acquisition of Multi-Drug Resistance and Associations With Functional Microbiome Characterization: Is There Any There There?
33. The Role of the AggR Regulon in the Virulence of the Shiga Toxin-Producing Enteroaggregative Escherichia coli Epidemic O104:H4 Strain in Mice
34. Shiga Toxin Type 1a (Stx1a) Reduces the Toxicity of the More Potent Stx2a In Vivo and In Vitro
35. Elastase in Intestinal Mucus Enhances the Cytotoxicity of Shiga Toxin Type 2d
36. Mapping of genetic loci that modulate differential colonization by Escherichia coli O157:H7 TUV86-2 in advanced recombinant inbred BXD mice
37. Virulence Potential of Activatable Shiga Toxin 2d-Producing Escherichia coli Isolates from Fresh Produce
38. Reduced Toxicity of Shiga Toxin (Stx) Type 2c in Mice Compared to Stx2d Is Associated with Instability of Stx2c Holotoxin
39. Shiga toxin 2a and EnteroaggregativeEscherichia coli– a deadly combination
40. Escherichia coli O157:H7 Infection in Dutch Belted and New Zealand White Rabbits
41. Protective Efficacy and Pharmacokinetics of Human/Mouse Chimeric Anti-Stx1 and Anti-Stx2 Antibodies in Mice
42. Animal Models for STEC-Mediated Disease
43. Clinical Isolates of Shiga Toxin 1a–ProducingShigella flexneriwith an Epidemiological Link to Recent Travel to Hispañiola
44. New Therapeutic Developments against Shiga Toxin-Producing Escherichia coli
45. Shiga Toxin (Stx) Classification, Structure, and Function
46. Comparisons of Native Shiga Toxins (Stxs) Type 1 and 2 with Chimeric Toxins Indicate that the Source of the Binding Subunit Dictates Degree of Toxicity
47. Pathogenesis of Escherichia coli O157:H7 Strain 86-24 Following Oral Infection of BALB/c Mice with an Intact Commensal Flora
48. Shiga Toxin Type 2dact Displays Increased Binding to Globotriaosylceramide in vitro and Increased Lethality in Mice after Activation by Elastase
49. Ricin Crosses Polarized Human Intestinal Cells and Intestines of Ricin-Gavaged Mice without Evident Damage and Then Disseminates to Mouse Kidneys
50. Virulence of the Shiga Toxin Type 2-Expressing Escherichia coli O104:H4 German Outbreak Isolate in Two Animal Models
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.